Rebecca Jones
Senior Director Program Management @Novavax
Signup · Get unlimited contacts
WORK HISTORY
Senior Director Program Management @Novavax
Program Team Lead: COVID-19 Vaccine (Commercial Product)Program Team Lead: COVID Influenza Combo (CIC)(Phase 3)Program Team Lead: Trivalent Nanoparticle Influenza (Phase 3)• Drive program goals and strategy, decision making, risk management, prioritization, and collaboration – at the working team level and as a thought partner with executive leaders. • Direct end-to-end integrated project plans for cross functional teams and ensure seamless execution in very fast-paced and dynamic drug development programs.• Effective communicator that ensures visibility and reporting on program deliverables, risks, and status at all levels of the organization. • Pioneered the cutting-edge strain change strategy to be market competitive & provide a protein-based COVID-19 vaccine option.• Lead weekly Program Teams. Communicate regularly with Executive Team. • Collaborate regularly across all functions including R&D, Preclinical, Clinical Development, Technical Operations, Regulatory, Quality, Supply Chain, Commercial.Accomplishments:• Developed program management best practices, standards and governance processes that are applied to all Novavax programs. • Ensured on-time regulatory submissions and season launch for COVID strain change to enable a protein-based vaccine option for the public in markets worldwide.• Launched Strain Selection Committee, which monitors COVID and Flu strain development, world-wide strain emergence, industry trends, and government policy decisions. Facilitate committee; drive strategy and decision making.• Oversaw development of corporate processes for COVID annual strain change and timelines. • Performance driven promotions twice in 2 years: Associate Director to Director to Senior Director.
EDUCATION
Colorado State University
BS, Biochemistry
SKILLS
ABOUT REBECCA JONES
Strategic and results-driven Program Management Professional with 15+ years leading cross-functional drug development teams from early research through regulatory approval and global launch. Focused on action, with deep expertise in overseeing complex and high-impact programs. Exceptional at translating scientific, clinical, regulatory, and CMC complexity into clear, actionable strategy that drives alignment, accelerates decision-making, and sustains progress in fast-paced environments. Recognized for consistently delivering on corporate objectives, often on timelines faster than industry standard. Known for building trust across diverse stakeholders, mentoring & empowering team members, and establishing nimble governance frameworks.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.